Your shopping cart is currently empty

MG-3C is a potent inhibitor of matrix metalloproteinase 9 (MMP-9). It selectively targets and kills non-small cell lung cancer (NSCLC) cells harboring the EGFR T790M mutation. By blocking the EGFR/STAT3 signaling pathway, MG-3C induces cell cycle arrest at the G2/M phase, inhibits growth, and triggers apoptosis. This compound shows potential for lung cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | MG-3C is a potent inhibitor of matrix metalloproteinase 9 (MMP-9). It selectively targets and kills non-small cell lung cancer (NSCLC) cells harboring the EGFR T790M mutation. By blocking the EGFR/STAT3 signaling pathway, MG-3C induces cell cycle arrest at the G2/M phase, inhibits growth, and triggers apoptosis. This compound shows potential for lung cancer research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.